| Financial Year |
March 31 2023 |
| Monetary Funds |
361,421,236.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
342,313,364.85 |
| Accounts Receivable |
351,546,511.55 |
| Advances to Suppliers |
13,074,775.74 |
| Other Receivables |
10,885,781.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
254,842,940.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,805,029.48 |
| Other Current Assets |
22,305,534.00 |
| Total Current Assets |
1,590,536,383.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
15,732,466.01 |
| Long-term Equity Investment |
43,715,293.05 |
| Investment Properties |
-- |
| Fixed Assetes |
1,073,448,325.08 |
| Under-construction Projects |
289,166,569.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,427,802.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,511,430.95 |
| Deferred Income Tax Assets |
22,827,752.05 |
| Other Non-Current Assets |
109,944,268.18 |
| Sub-Total of Non-Current Assets |
1,682,244,613.40 |
| Total Assets |
3,272,780,997.13 |
| Short-Term Loans |
360,870,934.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
85,000,000.00 |
| Accounts Payable |
96,478,770.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,079,188.14 |
| Taxes Payable |
6,209,598.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,244,731.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
107,094,065.08 |
| Other Current Liabilities |
130,581,275.29 |
| Sub-Total of Current Liabilities |
800,189,194.36 |
| Long-term Loans |
331,130,000.00 |
| Bonds Payable |
392,210,336.15 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
175,065.39 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
753,733,256.84 |
| Total Liabilities |
1,553,922,451.20 |
| Paid-In Capital(Or Share Stock) |
165,952,919.00 |
| Capital Surplus |
722,377,193.64 |
| Surplus Reserve |
63,208,303.21 |
| LESS:Treasury Stock |
35,002,883.00 |
| Undistributed Profits |
686,672,084.46 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,718,858,545.93 |
| Owner's Equity（Stockholder's Equity） |
1,718,858,545.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,272,780,997.13 |
